COVID-19 and Hypopituitarism
August 2021
in “
Reviews in endocrine and metabolic disorders
”
hypopituitarism pituitary gland arterial hypertension hyperglycemia obesity vertebral fractures pituitary apoplexy adrenal insufficiency cardiovascular risk infection risk growth hormone deficiency diabetes insipidus high blood pressure high blood sugar spinal fractures adrenal gland failure heart disease risk GHD DI
Studysummary This review discusses hypopituitarism's bidirectional relationship with COVID-19 due to metabolic comorbidities and pituitary risks, but it reports no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer